Out-of-favour Delling delivered disappointing results for calendar 2007, reflecting a poor third quarter and problems with a loss-making subsidiary.
The only quoted marketing support services company whose assets are in Scandinavia reported pre-tax losses of £3.4m (2006: £5.2m), despite 67% sales growth to £17.5m, which reflected organic as well as acquisitive development.
Considerable crumbs of comfort for Delling, a leading player in the Scandinavian design and exhibitions sector, included a reduction in EBITDA losses to £1.96m (2006: £4.4m), ongoing progress in turning around its troublesome subsidiary and a return to form in the fourth quarter. Having taken considerable cost out of the business and restructured operations in Sweden and Norway, a profit at EBITDA level was delivered for the first quarter of 2008.
For now, executive chairman Aksel Bratvedt says acquisitions are on the back burner, with organic growth the focus until sustainable profitability is reached. Moreover, despite global economic concerns, he is ‘reasonably optimistic about the Scandinavian markets’, since these economies are ‘robust’ and at a different stage in the business cycle to the Anglo-Saxon economies. And while Delling is dependent on marketing budgets, he believes the downturn could play into the hands of its outsourcing operations, where the company is now able to handle increasingly large contracts.
A disappointing investment to date, there is every indication that a decent turnaround is in progress at Delling. However, given investor sentiment towards marketing services ventures in current economic climes, the shares are probably best avoided for the time being.
Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.
Market cap: £4.28m
PE Forecast: n/a
Share price: 2.12p
More breaking news stories.
More extended feature articles.
And a depth of analysis you
can't find anywhere else.
Advertisement
VCT Report 2010 uncovers the money available
for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted
company.
Order VCT Report 2010 today using this online form
A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.
is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.
The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).
A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!
Small-cap and growth company share recommendations on AIM- and PLUS-listed companies. Latest analysts' stock tips and advice on which are the best shares to buy on London's junior stock markets.
Advertisement
Delcam, the international seller of CAD/CAM software to the engineering, aerospace and healthcare sectors among others, is a cash-generative small-cap seeing recovery in its markets.
Bombed-out biotech play Antisoma is hoping two of its drugs will lead to good fortune after experiencing disaster with lung cancer treatment ASA404.
London pub operator The Capital Pub Company is seeing continuing sales growth on the back of a surprisingly resilient market.